Multiple antimicrobial peptides showed synergistic cytotoxicity against Trypanosoma cruzi (Chagas disease parasite) and host bacteria, identifying peptide combination therapy for this neglected tropical disease.
Key findingMultiple antimicrobial peptides showed synergistic cytotoxicity against Trypanosoma cruzi (Chagas disease parasite) and host bacteria, identifying pep
What the researchers found
Multiple antimicrobial peptides showed synergistic cytotoxicity against Trypanosoma cruzi (Chagas disease parasite) and host bacteria, identifying peptide combination therapy for this neglected tropical disease.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Trypanosoma cruzi: synergistic cytotoxicity of multiple amphipathic anti-microbial peptides to T. cruzi and potential bacterial hosts.
Experimental parasitology, 125(4), 342-7
Citation
Fieck, Annabeth; Hurwitz, Ivy; Kang, Angray S; Durvasula, Ravi. (2010). Trypanosoma cruzi: synergistic cytotoxicity of multiple amphipathic anti-microbial peptides to T. cruzi and potential bacterial hosts.. Experimental parasitology, 125(4), 342-7. https://doi.org/10.1016/j.exppara.2010.02.016